APO IMA 400 (Imatinib Mesylate 400 mg)
Pill with imprint APO IMA 400 is Orange, Capsule-shape and has been identified as Imatinib Mesylate 400 mg. It is supplied by Apotex Corp..
Imatinib is used in the treatment of chronic myelogenous leukemia; gastrointestinal stromal tumor; chronic eosinophilic leukemia; myeloproliferative disorders; acute lymphoblastic leukemia (and more), and belongs to the drug class BCR-ABL tyrosine kinase inhibitors. There is positive evidence of human fetal risk during pregnancy. Imatinib 400 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for APO IMA 400
More about imatinib
- Imatinib Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Support Group
- Pricing & Coupons
- En Español
- 36 Reviews
- Drug class: BCR-ABL tyrosine kinase inhibitors
Other brands: Gleevec
Related treatment guides
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.